Felix Seyfried
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 04, 2026
Therapeutic potential of BH3-mimetics and NK cell-mediated immunotherapy in T-ALL.Colin Fortner, Alexandra Niedermayer, Melina Maria Bäuerle
|Apr 15, 2025
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax.Alexandra Niedermayer, Jana Stursberg, Anke Katharina Bergmann
|Oct 05, 2024
The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.Maren Christiane Wichert, Colin Fortner, Alexandra Niedermayer
|Jul 03, 2024
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation.Stefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried
Pageof 1
